ANKHCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。ANKH遺伝子サイレンサーは、ANKH CRISPR/Cas9ノックアウトプラスミドとANKHDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のANKHCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
ANKH CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
ANKH CRISPR/Cas9 KOプラスミド (h) | sc-408475 | h | Gene Knockout | GFP | 0 | ||
ANKH HDRプラスミド (h) | sc-408475-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ANKH Double Nickaseプラスミド (h) | sc-408475-NIC | h | Gene Knockout | Puromycin | 0 | ||
ANKH Double Nickaseプラスミド (h2) | sc-408475-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ANKH CRISPR/Cas9 KOプラスミド (m) | sc-419107 | m | Gene Knockout | GFP | 0 | ||
ANKH CRISPR/Cas9 KOプラスミド (m2) | sc-419107-KO-2 | m | Gene Knockout | GFP | 0 | ||
ANKH Double Nickaseプラスミド (m) | sc-419107-NIC | m | Gene Knockout | Puromycin | 0 | ||
ANKH Double Nickaseプラスミド (m2) | sc-419107-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ANKHD1 CRISPR/Cas9 KOプラスミド (h2) | sc-405893-KO-2 | h | Gene Knockout | GFP | 0 | ||
ANKHD1 HDRプラスミド (h2) | sc-405893-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
ANKHD1 Double Nickaseプラスミド (h) | sc-405893-NIC | h | Gene Knockout | Puromycin | 0 | ||
ANKHD1 Double Nickaseプラスミド (h2) | sc-405893-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ANKHD1 CRISPR/Cas9 KOプラスミド (m) | sc-430866 | m | Gene Knockout | GFP | 0 | ||
ANKHD1 HDRプラスミド (m) | sc-430866-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ANKHD1 Double Nickaseプラスミド (m) | sc-430866-NIC | m | Gene Knockout | Puromycin | 0 | ||
ANKHD1 Double Nickaseプラスミド (m2) | sc-430866-NIC-2 | m | Gene Knockout | Puromycin | 0 |
ANKH CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
ANKH CRISPR Activationプラスミド (h) | sc-408475-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANKH CRISPR Activationプラスミド (h2) | sc-408475-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANKH Lentiviral Activation Particles (h) | sc-408475-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANKH Lentiviral Activation Particles (h2) | sc-408475-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANKH CRISPR Activationプラスミド (m) | sc-419107-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANKH CRISPR Activationプラスミド (m2) | sc-419107-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANKH Lentiviral Activation Particles (m) | sc-419107-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANKH Lentiviral Activation Particles (m2) | sc-419107-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANKHD1 CRISPR Activationプラスミド (h) | sc-405893-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANKHD1 CRISPR Activationプラスミド (h2) | sc-405893-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANKHD1 Lentiviral Activation Particles (h) | sc-405893-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANKHD1 Lentiviral Activation Particles (h2) | sc-405893-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANKHD1 CRISPR Activationプラスミド (m) | sc-430866-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANKHD1 CRISPR Activationプラスミド (m2) | sc-430866-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANKHD1 Lentiviral Activation Particles (m) | sc-430866-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ANKHD1 Lentiviral Activation Particles (m2) | sc-430866-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |